Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
China Biotech Services Holdings, often referred to as CBSH, is a prominent player in the medical, precision, and optical instruments sector, headquartered in China (CN). Established in 2000, the company has made significant strides in providing innovative solutions within the biotechnology and healthcare industries.
With a focus on precision instruments and advanced medical technologies, CBSH offers a range of core products and services that stand out for their quality and reliability. The company has established a strong market position, recognised for its commitment to research and development, which has led to notable achievements in enhancing healthcare delivery.
Operating primarily in China, CBSH continues to expand its influence in the Asia-Pacific region, contributing to advancements in medical diagnostics and treatment methodologies. Its dedication to excellence and innovation solidifies its reputation as a leader in the biotechnology services landscape.
-10 vs industry average
China Biotech Services Holdings’s score of 22 is lower than 39% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing is among the most carbon-intensive industries
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
China Biotech Services Holdings, headquartered in CN, operates in the Medical, precision and optical instruments, watches and clocks industry. In 2023, the company's total reported emissions were approximately 843,000 kg CO2e. This included Scope 2 emissions of approximately 647,000 kg CO2e and Scope 3 emissions of about 63,700 kg CO2e, with business travel accounting for 48,000 kg CO2e and waste generated in operations for 5,600 kg CO2e.
Looking back, in 2022, China Biotech Services Holdings reported total emissions of approximately 11,273,000 kg CO2e, comprising about 11,237,000 kg CO2e from Scope 2 and 33,700 kg CO2e from Scope 3. In 2021, their total emissions were roughly 238,000 kg CO2e, with approximately 38,000 kg CO2e from Scope 1, 159,000 kg CO2e from Scope 2, and 40,900 kg CO2e from Scope 3. The company has not publicly disclosed any specific climate reduction targets or commitments.
No climate goals have been disclosed for China Biotech Services Holdings yet.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more